Literature DB >> 6442463

Compression bandage in the treatment of ankle sprains. A comparative prospective study.

F Linde, I Hvass, U Jürgensen, F Madsen.   

Abstract

The value of a compression bandage applied for 4 days following ankle sprains was assessed in a comparative study. The effect of the treatment was evaluated by changes in an inflammatory score based on a combination of subjective (pain, function) and objective (swelling, limitation of movement, pain on passive movement) factors. The study included two consecutive series each of 50 patients treated with a compression bandage, and untreated. There was no significant difference in the reduction of the inflammatory score from start to the fourth day (0.5 less than p less than 0.6) or from start to the eighth day (0.1 less than p less than 0.2) between the group treated with compression bandage and the untreated group. Analysis of the individual factors included in the inflammatory score demonstrated no difference in the course of pain, function, swelling, or limitation of movement between the two groups.

Entities:  

Mesh:

Year:  1984        PMID: 6442463

Source DB:  PubMed          Journal:  Scand J Rehabil Med        ISSN: 0036-5505


  3 in total

Review 1.  National Athletic Trainers' Association position statement: conservative management and prevention of ankle sprains in athletes.

Authors:  Thomas W Kaminski; Jay Hertel; Ned Amendola; Carrie L Docherty; Michael G Dolan; J Ty Hopkins; Eric Nussbaum; Wendy Poppy; Doug Richie
Journal:  J Athl Train       Date:  2013 Jul-Aug       Impact factor: 2.860

2.  Compression Wrapping for Acute Closed Extremity Joint Injuries: A Systematic Review.

Authors:  Vere Borra; David C Berry; David Zideman; Eunice Singletary; Emmy De Buck
Journal:  J Athl Train       Date:  2020-08-01       Impact factor: 2.860

3.  A randomised controlled trial to determine the effectiveness of double Tubigrip in grade 1 and 2 (mild to moderate) ankle sprains.

Authors:  B L Watts; B Armstrong
Journal:  Emerg Med J       Date:  2001-01       Impact factor: 2.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.